Aims and scope

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

  • Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.
  • Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

  • Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

  • Studies focusing on the application of drug delivery technology in healthcare.

  • Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.

All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.